{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17"}]}],"title":"rs6323"},{"categories":[{"measurements":[{"groupId":"OG000","value":"17"}]}],"title":"rs4680"},{"categories":[{"measurements":[{"groupId":"OG000","value":"17"}]}],"title":"rs6280"}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"description":"Types of genetic polymorphisms of neurotransmitters were examined. We studied 3 genetic polymorphisms; these were types of genetic polymorphisms involved in dopamine metabolism. They were as follows: rs6323, rs4680, and rs6280.","groups":[{"description":"Number of patients with neurotransmitter studies","id":"OG000","title":"Number of Patients With Neurotransmitter Studies"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Three genetic polymorphisms involved in dopamine metabolism (rs6323, rs4680, and rs6280) were studied in 17 patients with CNS neurotransmitter studies.","reportingStatus":"POSTED","timeFrame":"At study enrollment (Day 0)","title":"Number and Type of Genetic Polymorphisms","type":"SECONDARY","unitOfMeasure":"Participants"}